Ignite Creation Date:
2024-05-06 @ 5:33 PM
Last Modification Date:
2024-10-26 @ 2:30 PM
Study NCT ID:
NCT05342194
Status:
NOT_YET_RECRUITING
Last Update Posted:
2022-08-15
First Post:
2022-04-07
Brief Title:
Toripalimab Plus Lenvatinib and Gemcitabine-based Chemotherapy in 1L Treatment of Advanced ICC a Phase III Study
Sponsor:
Organization:
Shanghai Junshi Bioscience Co Ltd